Impact of autologous blood transfusions on surface marker and microRNA profiles of urinary extracellular vesicles

Abstract

Aim: Autologous blood transfusions (ABT), especially those involving stored erythrocyte concentrates (ECs), are known to be misused as performance enhancers in recreational and competitive athletes. EC storage not only increases the release of extracellular vesicles (EVs), but also significantly alters the microRNA profiles. Since re-transfused EVs also appear in urine, this study was designed to evaluate whether the urinary EV-associated microRNA load could serve as a valuable indicator in the challenging detection of ABT.

Methods: Thirty healthy, recreationally active males were included and equally divided into three groups. The control group did not donate or receive any blood components. Group 1 donated about 500 mL of whole blood once, which was subsequently processed into ECs. These were stored for six weeks and then re-infused into the respective donor. Group 2 donated about 500 mL of whole blood twice, at an interval of two weeks. The obtained ECs were stored for six or four weeks, respectively, until parallel re-infusion. In all groups, urine samples were collected over three consecutive weeks before whole-blood donation to establish each individual’s baseline, as well as before re-transfusion and several hours and days afterward. Urine samples were processed and analyzed for general urinary health and creatinine levels. Urinary EVs were further isolated by immunoaffinity and characterized using transmission electron microscopy, fluorescence nanoparticle tracking analysis, and western blotting, as well as an established multiplexed bead-based flow cytometry method, followed by RNA isolation and in-depth small RNA profiling using next-generation sequencing and comprehensive data analyses.

Results: Urinary EVs presented with typical morphology of small EVs (< 200 nm) and an overall concentration of 8.79 ± 7.00 × 10¹⁰ particles/g U_Crea (urinary creatinine). Significant increases in urinary EV concentrations were detected up to three days after ABT. Apart from Alix, Syntenin, and tumor susceptibility gene 101 (TSG101), surface markers CD63, CD9, CD133/1, CD24, CD326, CD81, and CD31 were also shown to be highly abundant on urinary EVs. Impurities or contaminations were not detected. Cluster analysis based on surface markers showed a clear separation between the control and ABT group. Furthermore, microRNA profiling revealed 13 microRNAs differently regulated upon ABT with miR-155-5p, miR-320b, and miR-6869-5p being the most abundant.

Conclusion: This proof-of-concept study suggests an impact of ABT on the urinary EV-microRNA cargo and yields comprehensive findings into surface markers of urinary EVs. While the adoption of urinary EV-associated microRNAs in routine doping tests requires further exploration, these data serve as a valuable basis for a variety of subsequent investigations.

Keywords

Urine / EV / miRNA / blood doping / transcriptomics / RNA sequencing / NGS / RAAS

References

[1] Jelkmann W.Autologous red blood cell transfusions in clinics and their misuse in sports.Dtsch Z Sportmed.2020;71:62-8

[2] Malm CB,Granlund I,Hult A.Autologous doping with cryopreserved red blood cells - effects on physical performance and detection by multivariate statistics.PLoS ONE.2016;11:e0156157 PMCID:PMC4902314

[3] World Anti-Doping Agency. World anti-doping code. Montreal: WADA; 2021. Available from: https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf. [Last accessed on 17 Nov 2025].

[4] World Anti-Doping Agency. Prohibited list 2024. Montreal: World Anti-Doping Agency; 2024. Available from: https://www.wada-ama.org/sites/default/files/2023-09/2024list_en_final_22_september_2023.pdf. [Last accessed on 17 Nov 2025].

[5] Nelson M,Sharpe K.Proof of homologous blood transfusion through quantification of blood group antigens.Haematologica2003;88:1284-95

[6] Krumm B,Botrè F,Faiss R.Indirect biomarkers of blood doping: A systematic review.Drug Test Anal.2023;16:49-64

[7] World Anti-Doping Agency. Athlete biological passport operating guidelines. Available from: https://www.wada-ama.org/sites/default/files/resources/files/guidelines_abp_v71.pdf. [Last accessed on 18 Nov 2025].

[8] Cyclingnews. Operation aderlass doctor mark schmidt jailed for almost five years. Available from: https://www.cyclingnews.com/news/operation-aderlass-doctor-mark-schmidt-jailed-for-almost-five-years/. [Last accessed on 18 Nov 2025].

[9] Riedmaier I,Meyer HHD.The physiological way: monitoring RNA expression changes as new approach to combat illegal growth promoter application.Drug Test Anal.2012;4:70-4

[10] Riedmaier I,Pfaffl MW.Identification of a potential gene expression biomarker signature in bovine liver to detect the abuse of growth promoters.Food Addit Contam Part A Chem Anal Control Expo Risk Assess.2014;31:641-9

[11] Neuberger E,Durussel J. Small RNA sequencing of red blood cell specific miRNAs reveals expression changes after 6 weeks of recombinant EPO (rEPO) administration in healthy recreational athletes. Available from: https://research.brighton.ac.uk/en/publications/small-rna-sequencing-of-red-blood-cell-specific-mirnas-reveals-ex/. [Last accessed on 18 Nov 2025].

[12] Leuenberger N,Pradervand S,Saugy M.Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse.Drug Test Anal.2011;3:771-6

[13] Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell2004;116:281-97

[14] Friedman RC,Burge CB.Most mammalian mRNAs are conserved targets of microRNAs.Genome Res.2009;19:92-105 PMCID:PMC2612969

[15] Guo H,Weissman JS.Mammalian microRNAs predominantly act to decrease target mRNA levels.Nature.2010;466:835-40 PMCID:PMC2990499

[16] Chen SY,Telen MJ,Zhang B.The genomic analysis of erythrocyte microRNA expression in sickle cell diseases.PLoS ONE.2008;3:e2360 PMCID:PMC2408759

[17] Sangokoya C,Chi JT.Isolation and characterization of microRNAs of human mature erythrocytes.Methods Mol Biol2010;667:193-203 PMCID:PMC4347925

[18] Sarachana T,Atreya CD.Evaluation of small noncoding RNAs in ex vivo stored human mature red blood cells: changes in noncoding RNA levels correlate with storage lesion events.Transfusion.2015;55:2672-83

[19] Haberberger A,Riedmaier I.Changes in the microRNA expression profile during blood storage.BMJ Open Sport Exerc Med.2018;4:e000354 PMCID:PMC6045755

[20] Kannan M.Differential profiling of human red blood cells during storage for 52 selected microRNAs.Transfusion.2010;50:1581-8

[21] Wannez A,Chatelain B,Dogné JM.Extracellular vesicles in red blood cell concentrates: an overview.Transfus Med Rev.2019;33:125-30

[22] Voss SC,Al‐thani AM.Analysis of RBC‐microparticles in stored whole blood bags - a promising marker to detect blood doping in sports?.Drug Test Anal.2017;9:1794-8

[23] Kuo WP,Toxavidis V.Red blood cells: a source of extracellular vesicles.Methods Mol Biol2017;1660:15-22

[24] Valadi H,Bossios A,Lee JJ.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat Cell Biol.2007;9:654-9

[25] Skog J,Van Rijn S.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat Cell Biol.2008;10:1470-6 PMCID:PMC3423894

[26] Raposo G,Stoorvogel W.B lymphocytes secrete antigen-presenting vesicles.J Exp Med.1996;183:1161-72 PMCID:PMC2192324

[27] Brzozowski JS,Bond DR.Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines.Lipids Health Dis.2018;17:211 PMCID:PMC6128989

[28] Huang X,Tschannen M.Characterization of human plasma-derived exosomal RNAs by deep sequencing.BMC Genomics.2013;14:319 PMCID:PMC3653748

[29] Jimenez L,Jung YJ.Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations.J Extracell Vesicles.2023;12:e12366 PMCID:PMC10603024

[30] Arroyo JD,Kroh EM.Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.Proc Natl Acad Sci U S A.2011;108:5003-8 PMCID:PMC3064324

[31] Turchinovich A,Langheinz A.Characterization of extracellular circulating microRNA.Nucleic Acids Res.2011;39:7223-33 PMCID:PMC3167594

[32] Barutta F,Corbelli A.Urinary exosomal microRNAs in incipient diabetic nephropathy.PLoS ONE.2013;8:e73798 PMCID:PMC3817183

[33] Long JD, Sullivan TB, Humphrey J, et al. A non-invasive miRNA based assay to detect bladder cancer in cell-free urine. Am J Transl Res. 2015;7:2500-9. Available from: https://www.ajtr.org/files/ajtr0015857.pdf. [Last accessed on 18 Nov 2025].

[34] Khurana R,Schafferer S.Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease.RNA.2017;23:142-52 PMCID:PMC5238789

[35] Solé C,Felip ML,Ordi-ros J.miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis.Nephrol Dial Transplant.2015;30:1488-96 PMCID:9271488

[36] Cheng Y,Yang J.A translational study of urine miRNAs in acute myocardial infarction.J Mol Cell Cardiol.2012;53:668-76 PMCID:PMC4492106

[37] Dhondt B,Vermaerke S.Urinary extracellular vesicle biomarkers in urological cancers: from discovery towards clinical implementation.Int J Biochem Cell Biol.2018;99:236-56

[38] World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA2013;310:2191-4

[39] World Anti-Doping Agency. Urine sample collection guidelines. Available from: https://www.wada-ama.org/sites/default/files/resources/files/wada_guidelines_urine_sample_collection_2014_v1.0_en.pdf. [Last accessed on 18 Nov 2025].

[40] World Anti-Doping Agency. Guidelines for sample collection. Available from: https://www.wada-ama.org/sites/default/files/2023-11/sample_collection_final.pdf. [Last accessed on 18 Nov 2025].

[41] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles.2018;7:1535750 PMCID:PMC6322352

[42] Welsh JA,O'driscoll L.MISEV consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches.J Extracell Vesicles.2024;13:e12404 PMCID:PMC10850029

[43] Mussack V,Pfaffl MW.On the trail of blood doping - fingerprints to monitor autologous blood transfusions in vivo.Am J Hematol.2021;96:338-53

[44] Department of Health, Education, and Welfare, National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The belmont report. Ethical principles and guidelines for the protection of human subjects of research.J Am Coll Dent2014;81:4-13

[45] Rosner B. Fundamentals of biostatistics. Cengage Learning; 2010. Available from: https://studylib.net/doc/27109472/fundamentals-of-biostatistics--7th-edition-. [Last accessed on 18 Nov 2025].

[46] Bundesanzeiger Verlag. Bekanntmachung der neufassung des transfusionsgesetzes. Available from: https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&bk=Bundesanzeiger_BGBl&start=//*[@attr_id=%27bgbl107s2169.pdf%27]#/switch/tocPane?_ts=1763430811235. [Last accessed on 18 Nov 2025].

[47] Erdbrügger U,Bijnsdorp IV.Urinary extracellular vesicles: a position paper by the Urine Task Force of the International Society for Extracellular Vesicles.J Extracell Vesicles.2021;10:e12093 PMCID:PMC8138533

[48] Théry C.ISEV2018 abstract book.J of Extracellular Vesicle.2018;7:1461450

[49] Zhou H,Pisitkun T.Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery.Kidney Int.2006;69:1471-6 PMCID:PMC2276656

[50] Delanghe JR.Creatinine determination according to Jaffe--what does it stand for?.NDT Plus.2011;4:83-6 PMCID:PMC4421578

[51] Mussack V,Pfaffl MW.Comparing small urinary extracellular vesicle purification methods with a view to RNA sequencing - enabling robust and non-invasive biomarker research.Biomol Detect Quantif.2019;17:100089 PMCID:PMC6554496

[52] Eitan E,Bodogai M.Age-related changes in plasma extracellular vesicle characteristics and internalization by leukocytes.Sci Rep.2017;7:1342 PMCID:PMC5430958

[53] Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57:289-300. Available from: https://www.jstor.org/stable/2346101. [Last accessed on 18 Nov 2025].

[54] BD Biosciences. FlowJo^TM software. Available from: https://www.bdbiosciences.com/en-us/products/software/flowjo-software?tab=flowJo-v11-software. [Last accessed on 18 Nov 2025].

[55] Kolde R. pheatmap: Pretty heatmaps. Available from: https://raivokolde.r-universe.dev/pheatmap. [Last accessed on 18 Nov 2025].

[56] R Core Team. The R project for statistical computing. Available from: https://www.r-project.org/. [Last accessed on 18 Nov 2025].

[57] Schroeder A,Stocker S.The RIN: an RNA integrity number for assigning integrity values to RNA measurements.BMC Mol Biol.2006;7:3 PMCID:PMC1413964

[58] Andrews S. FastQC: a quality control tool for high throughput sequence data. Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/. [Last accessed on 18 Nov 2025].

[59] Kong Y.Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies.Genomics.2011;98:152-3

[60] Petrov AI,Kalvari I.RNAcentral: a comprehensive database of non-coding RNA sequences.Nucleic Acids Res.2017;45:D128-34

[61] Kozomara A.miRBase: annotating high confidence microRNAs using deep sequencing data.Nucleic Acids Res.2014;42:D68-73 PMCID:PMC3965103

[62] Langmead B,Pop M.Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.Genome Biol.2009;10:R25 PMCID:PMC2690996

[63] Dessau RB.[“R”--project for statistical computing].Ugeskr Laeger2008;170:328-30

[64] Love MI,Anders S.Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol.2014;15:550 PMCID:PMC4302049

[65] Gentleman RC,Bates DM.Bioconductor: open software development for computational biology and bioinformatics.Genome Biol.2004;5:R80 PMCID:PMC545600

[66] Wickham H. ggplot2: elegant graphics for data analysis. Springer-Verlag New York; 2016. Available from: https://ggplot2-book.org/. [Last accessed on 18 Nov 2025].

[67] Van Deun J,Agostinis P.EV-TRACK Consortium. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.Nat Methods.2017;14:228-32

[68] Koliha N,Heider U.A novel multiplex bead‐based platform highlights the diversity of extracellular vesicles.J Extracell Vesicles.2016;5:29975 PMCID:PMC4762227

[69] Willekens FLA,Kruijt JK.Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors.Blood.2005;105:2141-5

[70] Yáñez‐mó M,Andreu Z.Biological properties of extracellular vesicles and their physiological functions.J Extracell Vesicles.2015;4:27066 PMCID:PMC4433489

[71] Voss SC,Grivel JC.Red blood cell derived extracellular vesicles during the process of autologous blood doping.Drug Test Anal.2021;14:1984-94

[72] Dimuccio V,Praticò Barbato L.Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage.PLoS ONE.2014;9:e104490 PMCID:PMC4123993

[73] Keller S,Stoeck A.CD24 is a marker of exosomes secreted into urine and amniotic fluid.Kidney Int.2007;72:1095-102

[74] Clevers H,Wileman T.The T cell receptor/CD3 complex: a dynamic protein ensemble.Annu Rev Immunol.1988;6:629-62

[75] Altin JG.The role of CD45 and CD45-associated molecules in T cell activation.Immunol Cell Biol.1997;75:430-45

[76] Mussack V. The role of microRNAs and extracellular vesicles in the detection of autologous blood doping. Available from: https://mediatum.ub.tum.de/doc/1615908/document.pdf. [Last accessed on 18 Nov 2025].

[77] Pacurari M.Role of microRNAs in renin-angiotensin-aldosterone system-mediated cardiovascular inflammation and remodeling.Int J Inflam.2015;2015:101527 PMCID:PMC4438140

[78] Liu HH,Liu JF.miR-6869-5p transported by plasma extracellular vesicles mediates renal tubule injury and renin-angiotensin system activation in obesity.Front Med.2021;8:725598 PMCID:PMC8455906

[79] Shen M,Li X.The role of miR-155 in urologic malignancies.Biomed Pharmacother.2024;174:116412

[80] Jafarzadeh A,Shojaie L.MicroRNA-155 and antiviral immune responses.Int Immunopharmacol.2021;101:108188

[81] Zingale VD,Mazzon E.MiR-155: an important regulator of neuroinflammation.Int J Mol Sci.2021;23:90 PMCID:PMC8745074

[82] Masaki S,Abe Y,Umemura T.Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis.Biochem Biophys Res Commun.2007;364:509-14

[83] Ali H,Abu‐farha M.Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease.J Gene Med.2024;26:e3674

[84] Kehl T,Backes C.miRPathDB 2.0: a novel release of the miRNA pathway dictionary database.Nucleic Acids Res.2020;48:D142-7 PMCID:PMC7145528